Alaunos Therapeutics | ZIOP - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Alaunos Therapeutics USD 2.21M 131K 2025-09
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Baxter International USD 516.45M 2.17M 2026-03
Biogen USD 146.7M 200K 2025-09
Bioline Rx USD 2.61B 53.2M 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celltrion KRW 218.61M 162.21K 2025-12
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Curis USD 12.93M 12.87M 2025-12
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 0 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Incyte USD 199.95M 1.49M 2026-03
Intrexon USD 0 0 2024-06
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
J&J USD 2.41B 1.74M 2025-12
Kangmei Pharma CNY 13.83B 34.97M 2025-09
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Merck USD 2.47B 12.72M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Novartis USD 1.91B 60K 2026-03
Organigram Holdings CAD 135.13M 671.75K 2025-12
Ovoca Bio EUR 29.49M 18.43M 2025-06
Pfizer USD 5.7B 13M 2026-03
Pharma Mar EUR 17.36M 0 2026-03
PTC Therapeutics USD 81.47M 1.54M 2025-12
Qiagen NV USD 216.56M 284.67K 2025-12
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sartorius EUR 69.05M 0 2026-03
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
TG Therapeutics USD 155.31M 95K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Verastem USD 77.74M 77.74M 2025-12
Zealand Pharma A/S 70.61M 319.68K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03